Upper Respiratory Tract Infection Clinical Trial
Official title:
Homeopathic Cold Medicine for Children
NCT number | NCT00858494 |
Other study ID # | 35537 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 2009 |
Est. completion date | October 2009 |
Verified date | July 2018 |
Source | University of Washington |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to determine if a commercially available homeopathic cold remedy for children is effective in providing relief from cold symptoms in children 2-5 years old. It is postulated that children will have relief of symptoms after receiving a dose of the cold remedy
Status | Completed |
Enrollment | 50 |
Est. completion date | October 2009 |
Est. primary completion date | October 2009 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 24 Months to 59 Months |
Eligibility |
Inclusion Criteria: - Children 24-59 months old - Cold/cough symptoms of <7 days duration - Diagnosed with upper respiratory tract infection by physician or nurse practitioner - Parent who speaks and reads English Exclusion Criteria: - Use of chronic medication other than multivitamins - History of asthma - Medication other than acetaminophen or ibuprofen - Use of homeopathic remedy within preceding 30 days - Only 1 participant per family |
Country | Name | City | State |
---|---|---|---|
United States | University of Washington Medical Center-Roosevelt Pediatric Care Center | Seattle | Washington |
Lead Sponsor | Collaborator |
---|---|
University of Washington | Standard Homeopathic Company |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Relief of Upper Respiratory Tract Infection (URI) Symptoms (Cough, Runny Nose, Nasal Congestion, Sneezing)1 Hour After Dose of Homeopathic Remedy. | For each dose of study medication, parents indicated which of the symptoms were present (runny nose, cough, nasal congestion, sneezing). Parents rated change in each symptom present one hour after a dose of study medication for up to 6 doses in study logs. Responses were dichotomized as at least some improvement or better (improvement) vs. no improvement or worse. The outcome measure is number of times that improvement in a specific symptom was noted after a dose of the homeopathic remedy. Completed study logs were received from 37 of 49 enrolled participants. | up to 10 days from index visit | |
Secondary | Parental Report of an Adverse Event After a Dose of Study Medication | After each dose of study medication parents reported the presence of any adverse events | data collected after doses occurring up to 10 days after index visit |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06052540 -
Probiotic Supplementation in Children Affected by Upper Respiratory Infections
|
N/A | |
Completed |
NCT04960878 -
The Effect of Synbiotics on the Upper Respiratory Tract Infection
|
N/A | |
Terminated |
NCT00979667 -
A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection
|
Phase 3 | |
Recruiting |
NCT04479657 -
Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection
|
Early Phase 1 | |
Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
Recruiting |
NCT06065176 -
The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection
|
Phase 4 | |
Recruiting |
NCT01985620 -
The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate.
|
N/A | |
Completed |
NCT01875757 -
Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life
|
Phase 3 | |
Recruiting |
NCT00551382 -
Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children: a Randomised, Double-blind, Placebo-controlled Study
|
Phase 3 | |
Completed |
NCT00393835 -
A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis
|
Phase 3 | |
Not yet recruiting |
NCT05612893 -
Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study
|
||
Completed |
NCT06149117 -
Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China
|
Phase 4 | |
Active, not recruiting |
NCT05569330 -
Effect of Aerosol Filtering on Infectious Diseases in Day Care
|
N/A | |
Recruiting |
NCT05374070 -
Antiviral Activity of Oral Probiotics
|
N/A | |
Completed |
NCT00707941 -
Oseltamivir Randomised Controlled Efficacy Trial
|
Phase 3 | |
Completed |
NCT04955327 -
To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI
|
Phase 3 | |
Completed |
NCT01735084 -
Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life
|
Phase 4 | |
Not yet recruiting |
NCT03461692 -
A Registry Study of 100 Thousand Cases of Pediatric Patients on Reduning Injection(a Chinese Medicine Injection)Used in Hospitals in China
|
N/A | |
Completed |
NCT03011515 -
Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)
|
||
Recruiting |
NCT05915390 -
Walnut and Immunity Study
|
N/A |